FINHUB Insights

BAX · Q2 FY26 · Apr 1 – Jun 30, 2026

Baxter International Q2 FY26: where the revenue came from and where it went

Baxter International Q2 FY26: revenue $3.0B (+5% year over year). Net profit $0.13B. Largest cohort Medical… Therapies $2.1B. The whole income statement as a sankey diagram from the SEC filing.

Period
Apr 1 – Jun 30, 2026
Reported
Jul 30, 2026 10-Q
Sankey diagram of Baxter International's income statement for Q2 FY26: revenue of $2.96 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$2.96B +5% year over year
Gross profit$1.03B 35% margin
Operating profit$0.22B 7% margin
Net profit$0.13B 4% margin

The numbers

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Jun 30, 2026).
ItemValueShare of revenueYear over year
Revenue 2.96 100% +5%
Medical… Therapies 2.08 70%
Healthcare… Technologies 0.80 27% +4%
Other 0.08 3% −25%
Cost of revenue−1.9365%
Gross profit1.0335% margin+0pp
Research & development−0.134%+0pp
SG&A−0.6923%−1pp
Operating profit0.227% margin+1pp
Tax−0.02
Interest & other costs−0.07
Net profit0.134%+1pp
Filing on EDGAR More quarters of BAX

Source of the numbers: tables in the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters